NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
14.47
+0.19 (1.33%)
Aug 18, 2026, 4:00 PM EDT - Market closed
NeuroPace Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 106.99 | 99.99 | 79.91 | 65.42 | 45.52 | 45.18 | |
Revenue Growth | 33.16% | 25.13% | 22.14% | 43.72% | 0.75% | 9.83% |
Cost of Revenue | 24.2 | 22.77 | 20.82 | 17.3 | 13.03 | 11.75 |
Gross Profit | 82.79 | 77.22 | 59.09 | 48.12 | 32.49 | 33.44 |
Selling, General & Admin | 67.24 | 65.67 | 57.1 | 54.52 | 51.34 | 38.96 |
Research & Development | 27.69 | 27.89 | 23.65 | 20.78 | 21.95 | 18.21 |
Operating Expenses | 94.93 | 93.56 | 80.76 | 75.3 | 73.29 | 57.17 |
Operating Income | -12.14 | -16.34 | -21.67 | -27.17 | -40.79 | -23.74 |
Interest Expense | -6.31 | -7.46 | -8.8 | -8.52 | -7.53 | -7.41 |
Interest & Investment Income | 2.39 | 2.82 | 3.02 | 3.05 | 1.58 | 0.45 |
Other Non Operating Income (Expenses) | 0.34 | -0.03 | 0.08 | - | 0.02 | -5.38 |
EBT Excluding Unusual Items | -15.71 | -21.01 | -27.37 | -32.64 | -46.73 | -36.08 |
Gain (Loss) on Sale of Investments | 0.04 | 0.04 | 0.23 | -0.32 | -0.36 | - |
Other Unusual Items | -0.5 | -0.5 | - | - | - | - |
Pretax Income | -16.17 | -21.47 | -27.14 | -32.96 | -47.08 | -36.08 |
Net Income | -19.11 | -21.47 | -27.14 | -32.96 | -47.08 | -36.08 |
Net Income to Common | -19.11 | -21.47 | -27.14 | -32.96 | -47.08 | -36.08 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 34 | 33 | 29 | 26 | 25 | 17 |
Shares Outstanding (Diluted) | 34 | 33 | 29 | 26 | 25 | 17 |
Shares Change | 8.60% | 12.35% | 12.67% | 5.11% | 48.08% | 8038.86% |
EPS (Basic) | -0.57 | -0.66 | -0.93 | -1.27 | -1.91 | -2.17 |
EPS (Diluted) | -0.57 | -0.66 | -0.93 | -1.27 | -1.91 | -2.17 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -11.61 | -11.34 | -18.26 | -19.87 | -37.47 | -24.96 |
Free Cash Flow Per Share | -0.35 | -0.35 | -0.63 | -0.77 | -1.52 | -1.50 |
Gross Margin | 77.38% | 77.23% | 73.94% | 73.56% | 71.38% | 74.00% |
Operating Margin | -11.34% | -16.34% | -27.12% | -41.54% | -89.62% | -52.53% |
Profit Margin | -17.87% | -21.47% | -33.97% | -50.38% | -103.43% | -79.85% |
Free Cash Flow Margin | -10.85% | -11.34% | -22.85% | -30.38% | -82.32% | -55.24% |
EBITDA | -11.88 | -16.1 | -21.46 | -27 | -40.53 | -23.44 |
EBITDA Margin | -11.10% | -16.10% | -26.86% | -41.27% | -89.03% | -51.88% |
D&A For EBITDA | 0.26 | 0.24 | 0.21 | 0.17 | 0.27 | 0.3 |
EBIT | -12.14 | -16.34 | -21.67 | -27.17 | -40.79 | -23.74 |
EBIT Margin | -11.34% | -16.34% | -27.12% | -41.54% | -89.62% | -52.53% |
Advertising Expenses | - | 0.5 | 0.7 | 0.7 | 0.7 | 0.1 |